OpenCitations
Works that cite this article, indexed by OpenCitations.
Discovery of Novel KuE PSMA PET Tracers through Structure Fine-Tuning and Direct Photocatalyzed 18F-Deoxyfluorination
Journal of Medicinal Chemistry 68(14) (2025)
Yueqi Wang; Mingxing Hu; Junjie Wu; Lili Pan; Huijun Zhou; Li Li; Weihong Kuang; Yongmei Xie; Wei Chen
Prostate cancer: Advances in diagnostic research
Diagnostic Landscape in Cancer Research (2025)
Emmanuel Kwaku Ofori; Nathaniel Ebo Aidoo
Prostate cancer and pollution: Dangerous connections
Annales d'Endocrinologie 86(3) (2025)
Sébastien Magnifico; Charlotte Hinault-Boyer; Frédéric Bost; Nicolas Chevalier
Characterizing high-risk SPOP mutations in prostate cancer: Insights from computational analysis and protein-ligand docking
In Silico Research in Biomedicine 1 (2025)
Memona Aslam; Aman Ullah; Maqsood Ahmad; Ali Umar; Misbah Ullah Khan; Muhammad Zia Ahmad; Muhammad Saleem Khan
Remodeling of androgen metabolism network mediated by UGT2B: a new perspective on treatment resistance in prostate cancer
European Journal of Pharmacology 1015 (2026)
YuanYuan Wang; Chenxi Tu; Hao Qin; Yingying Ma; Yukai Yang; Yinhua Xiong; Liang Peng; Lin Zhang
A comparative study of peptide-based imaging agents [68Ga]Ga-PSMA-11, [68Ga]Ga-AMBA, [68Ga]Ga-NODAGA-RGD and [68Ga]Ga-DOTA-NT-20.3 in preclinical prostate tumour models
Nuclear Medicine and Biology 84-85 (2020)
Jules Zhang-Yin; Claire Provost; Géraldine Cancel-Tassin; Timofei Rusu; Mallaurie Penent; Camelia Radulescu; Eva Comperat; Olivier Cussenot; Françoise Montravers; Raphaële Renard-Penna; Jean-Noël Talbot; Aurélie Prignon
Chromatin Remodeler Mutations in Human Cancers: Epigenetic Implications
Epigenomics 6(4) (2014)
Katherine A Skulte; Lisa Phan; Susan J Clark; Phillippa C Taberlay
Prostate Cancer
International Manual of Oncology Practice (2019)
Helena Luna Pais; João Ulrich; Leonor Ribeiro
Genetic polymorphisms of human UDP-glucuronosyltransferase (UGT) genes and cancer risk
Drug Metabolism Reviews 48(1) (2016)
Dong Gui Hu; Peter I. Mackenzie; Ross A. McKinnon; Robyn Meech
The Somatic Mutation Landscape of UDP-Glycosyltransferase (UGT) Genes in Human Cancers
Cancers 14(22) (2022)
Dong Gui Hu; Shashikanth Marri; Julie-Ann Hulin; Ross A. McKinnon; Peter I. Mackenzie; Robyn Meech
A common effect of angiotensin II and relaxin 2 on the PNT1A normal prostate epithelial cell line
Journal of Physiology and Biochemistry 72(3) (2016)
Kamila Domińska; Tomasz Ochędalski; Karolina Kowalska; Zuzanna E. Matysiak-Burzyńska; Elżbieta Płuciennik; Agnieszka W. Piastowska-Ciesielska
A Tale of Two Cancers: A Current Concise Overview of Breast and Prostate Cancer
Cancers 14(12) (2022)
Franklyn De Silva; Jane Alcorn
NDRG2 acts as a negative regulator downstream of androgen receptor and inhibits the growth of androgen-dependent and castration-resistant prostate cancer
Cancer Biology & Therapy 16(2) (2015)
Chuigong Yu; Guojun Wu; Ruixiao Li; Lei Gao; Fan Yang; Yi Zhao; Jian Zhang; Rui Zhang; Jing Zhang; Libo Yao; Jianlin Yuan; Xia Li
Recent Advances in the Development and Utilization of Nanoparticles for the Management of Malignant Solid Tumors
Cureus (2024)
Dhanashri D Chavan; Rohit R Bhosale; Vandana M Thorat; Amol S Shete; Sarika J Patil; Devkumar D Tiwari
Molecular MR Imaging of Prostate Cancer
Biomedicines 9(1) (2020)
Avan Kader; Julia Brangsch; Jan O. Kaufmann; Jing Zhao; Dilyana B. Mangarova; Jana Moeckel; Lisa C. Adams; Ingolf Sack; Matthias Taupitz; Bernd Hamm; Marcus R. Makowski
Synthesis and Preclinical Evaluation of [18F]SiFA-PSMA Inhibitors in a Prostate Cancer Model
Journal of Medicinal Chemistry 64(21) (2021)
Justin J. Bailey; Melinda Wuest; Michael Wagner; Atul Bhardwaj; Carmen Wängler; Bjoern Wängler; John F. Valliant; Ralf Schirrmacher; Frank Wuest
The prostate cancer immunome: In silico functional analysis of antigenic proteins from microarray profiling with IgG
PROTEOMICS 16(8) (2016)
Johana A. Luna‐Coronell; Klemens Vierlinger; Magdalena Gamperl; Johann Hofbauer; Ingrid Berger; Andreas Weinhäusel
Molecular imaging of prostate cancer: Review of imaging agents, modalities, and current status
Actas Urológicas Españolas (English Edition) 44(6) (2020)
J.M. Quesada-Olarte; M.E. Allaf; M. Alvarez-Maestro; L. Martínez-Piñeiroa
Molecular imaging for prostate cancer: Performance analysis of 68Ga-PSMA PET/CT versus choline PET/CT
Actas Urológicas Españolas (English Edition) 41(5) (2017)
L. Michaud; K.A. Touijer
Antineoplastic Effects of siRNA against TMPRSS2-ERG Junction Oncogene in Prostate Cancer
PLOS ONE 10(5) (2015)
Giorgia Urbinati; Hafiz Muhammad Ali; Quentin Rousseau; Hubert Chapuis; Didier Desmaële; Patrick Couvreur; Liliane Massaad-Massade
Imaging and Management of Prostate Cancer
Seminars in Ultrasound, CT and MRI 41(2) (2020)
Devaki Shilpa Sudha Surasi; Brian Chapin; Chad Tang; Gregory Ravizzini; Tharakeswara Kumar Bathala
Prostate Cancer
International Manual of Oncology Practice (2015)
Arlindo R. Ferreira; André Abrunhosa-Branquinho; Inês Vendrell; António Quintela; Filomena Pina; Leonor Ribeiro
Positron emission tomography computed tomography in the diagnosis of prostate cancer
Karnataka Medical Journal 47 (2024)
Rashmi Umesh Angadi
Role of Precision Oncology in Type II Endometrial and Prostate Cancers in the African Population: Global Cancer Genomics Disparities
International Journal of Molecular Sciences 23(2) (2022)
Rahaba Marima; Rodney Hull; Mandisa Mbeje; Thulo Molefi; Kgomotso Mathabe; Abdulrahman M. Elbagory; Demetra Demetriou; Zodwa Dlamini
Inhibition of prostatic cancer growth by ginsenoside Rh2
Tumor Biology 36(4) (2014)
Qingchuan Zhang; Bin Hong; Songhua Wu; Tianli Niu
Targeting SMAD3 for inhibiting prostate cancer metastasis
Tumor Biology 35(9) (2014)
Qing Xia; Chengjiang Li; Pingda Bian; Jue Wang; Shuai Dong
Molecular Imaging of Prostate Cancer
RadioGraphics 36(1) (2016)
Andreas G. Wibmer; Irene A. Burger; Evis Sala; Hedvig Hricak; Wolfgang A. Weber; Hebert Alberto Vargas
Molecular characterization of an MLL1 fusion and its role in chromosomal instability
Molecular Oncology 13(2) (2018)
Sreejit Parameswaran; Frederick S. Vizeacoumar; Kalpana Kalyanasundaram Bhanumathy; Fujun Qin; Md. Fahmid Islam; Behzad M. Toosi; Chelsea E. Cunningham; Darrell D. Mousseau; Maruti C. Uppalapati; Peter C. Stirling; Yuliang Wu; Keith Bonham; Andrew Freywald; Hui Li; Franco J. Vizeacoumar
TRPM4 regulates Akt/GSK3‐β activity and enhances β‐catenin signaling and cell proliferation in prostate cancer cells
Molecular Oncology 12(2) (2017)
Alfredo I. Sagredo; Eduardo A. Sagredo; Claudio Cappelli; Pablo Báez; Rodrigo E. Andaur; Constanza Blanco; Julio C. Tapia; César Echeverría; Oscar Cerda; Andrés Stutzin; Felipe Simon; Katherine Marcelain; Ricardo Armisén
Oncolytic adenovirus-mediated therapy for prostate cancer
Oncolytic Virotherapy Volume 5 (2016)
Gunnel Hallden; Katrina Sweeney
Oncogenes
Holland‐Frei Cancer Medicine (2017)
Marco A. Pierotti; Milo Frattini; Francesca Molinari; Gabriella Sozzi; Carlo M. Croce
The Crosstalk between Prostate Cancer and Microbiota Inflammation: Nutraceutical Products Are Useful to Balance This Interplay?
Nutrients 12(9) (2020)
Felice Crocetto; Mariarosaria Boccellino; Biagio Barone; Erika Di Zazzo; Antonella Sciarra; Giovanni Galasso; Giuliana Settembre; Lucio Quagliuolo; Ciro Imbimbo; Silvia Boffo; Italo Francesco Angelillo; Marina Di Domenico
The Impact of Metabolic Syndrome and Type 2 Diabetes Mellitus on Prostate Cancer
Frontiers in Cell and Developmental Biology 10 (2022)
André P. Sousa; Raquel Costa; Marco G. Alves; Raquel Soares; Pilar Baylina; Rúben Fernandes
Flightless I Homolog Represses Prostate Cancer Progression through Targeting Androgen Receptor Signaling
Clinical Cancer Research 22(6) (2016)
Tao Wang; Wen Song; Yuan Chen; Ruibao Chen; Zhuo Liu; Licheng Wu; Mingchao Li; Jun Yang; Liang Wang; Jihong Liu; Zhangqun Ye; Chenguang Wang; Ke Chen
Human Prostate Cancer Hallmarks Map
Scientific Reports 6(1) (2016)
Dipamoy Datta; Md. Aftabuddin; Dinesh Kumar Gupta; Sanghamitra Raha; Prosenjit Sen
ACSS3 represses prostate cancer progression through downregulating lipid droplet-associated protein PLIN3
Theranostics 11(2) (2021)
Lijie Zhou; Zhengshuai Song; Junyi Hu; Lilong Liu; Yaxin Hou; Xiaoping Zhang; Xiong Yang; Ke Chen
Non-canonical androgen signaling pathways and implications in prostate cancer
Biochimica et Biophysica Acta (BBA) - Molecular Cell Research 1869(12) (2022)
Versha Dahiya; Gargi Bagchi
A Radiogenomic Approach for Decoding Molecular Mechanisms Underlying Tumor Progression in Prostate Cancer
Cancers 11(9) (2019)
Sarah Fischer; Mohamed Tahoun; Bastian Klaan; Kolja M. Thierfelder; Marc-André Weber; Bernd J. Krause; Oliver Hakenberg; Georg Fuellen; Mohamed Hamed
Intrarectal Lidocaine-Diltiazem-Meperidine Gel for Transrectal Ultrasound Guided Prostate Biopsy
Anesthesiology and Pain Medicine 5(3) (2015)
Farsad Imani; Yasaman Moghaddam; Reza Shariat Moharari; Farhad Etezadi; Mohammad Reza Khajavi; Seyed Reza Hosseini
The importance of plasma arginine level and its downstream metabolites in diagnosing prostate cancer
International Urology and Nephrology 51(11) (2019)
Ismail Selvi; Halil Basar; Numan Baydilli; Koza Murat; Ozlem Kaymaz
RETRACTED ARTICLE: SULF2 overexpression positively regulates tumorigenicity of human prostate cancer cells
Journal of Experimental & Clinical Cancer Research 34(1) (2015)
Carolina M Vicente; Marcelo A Lima; Helena B Nader; Leny Toma
Técnicas de imagen molecular en el cáncer de próstata: revisión de radiofármacos, modalidades y evidencia actual
Actas Urológicas Españolas 44(6) (2020)
J.M. Quesada-Olarte; M.E. Allaf; M. Alvarez-Maestro; L. Martínez-Piñeiro
Toma de imágenes molecular del cáncer de próstata: análisis de rendimiento de 68Ga-PSMA PET/TC frente a PET/TC colina
Actas Urológicas Españolas 41(5) (2017)
L. Michaud; K.A. Touijer
Network-based approach reveals Y chromosome influences prostate cancer susceptibility
Computers in Biology and Medicine 54 (2014)
Pegah Khosravi; Vahid H. Gazestani; Yazdan Asgari; Brian Law; Mehdi Sadeghi; Bahram Goliaei
The Prognostic and Therapeutic Potential of Fragile X Mental Retardation 1 (FMR1) Gene Expression in Prostate Adenocarcinoma: Insights into Survival Outcomes and Oncogenic Pathway Modulation
International Journal of Molecular Sciences 25(13) (2024)
Salem Baldi; Bushra Amer; Fawze Alnadari; Maged AL-Mogahed; Yaqin Gao; Yaser Gamallat
Nano-based Herbal Medicine: A New Candidate for Prostate Cancer Treatment?
Current Traditional Medicine 10(7) (2024)
Tayebe Pouryousefi-koodehi; Mohammad Saeed Kahrizi; Hossein Roghani-Shahraki; Fatemeh Rezaei-Tazangi; Reza Arefnezhad; Hossein Motedayyen
Flightless I Homolog Reverses Enzalutamide Resistance through PD-L1–Mediated Immune Evasion in Prostate Cancer
Cancer Immunology Research 9(7) (2021)
Hailong Ruan; Lin Bao; Zhen Tao; Ke Chen
Diagnostic and Prognostic Utility of a DNA Hypermethylated Gene Signature in Prostate Cancer
PLoS ONE 9(3) (2014)
Liang Kee Goh; Natalia Liem; Aadhitthya Vijayaraghavan; Gengbo Chen; Pei Li Lim; Kae-Jack Tay; Michelle Chang; John Soon Wah Low; Adita Joshi; Hong Hong Huang; Emarene Kalaw; Puay Hoon Tan; Wen-Son Hsieh; Wei Peng Yong; Joshi Alumkal; Hong Gee Sim
Biopolymer and Biomaterial Conjugated Iron Oxide Nanomaterials as Prostate Cancer Theranostic Agents: A Comprehensive Review
Symmetry 13(6) (2021)
Md. Abu Rayhan; Md. Sakib Hossen; Mahruba Sultana Niloy; Mozammel Haque Bhuiyan; Sudip Paul; Md. Salman Shakil
Racial disparity in prostate cancer in the African American population with actionable ideas and novel immunotherapies
Cancer Reports 4(5) (2021)
Zachary S. Dovey; Sujit S. Nair; Dimple Chakravarty; Ashutosh K. Tewari
Translationally Controlled Tumor Protein in Prostatic Adenocarcinoma: Correlation with Tumor Grading and Treatment-Related Changes
BioMed Research International 2015 (2015)
Bruno Jim Rocca; Alessandro Ginori; Aurora Barone; Calogera Calandra; Filippo Crivelli; Giulia De Falco; Sara Gazaneo; Sergio Tripodi; Gabriele Cevenini; Maria Teresa del Vecchio; Maria Raffaella Ambrosio; Piero Tosi
CURRENT PERSPECTIVES ON APPLICATIONS OF NANOPARTICLES FOR CANCER MANAGEMENT
International Journal of Pharmacy and Pharmaceutical Sciences (2023)
ROHIT R. BHOSALE; BHAGYESH U. JANUGADE; DHANASHRI D. CHAVAN; VANDANA M. THORAT
Retracted: Curcumin inhibits the survival and metastasis of prostate cancer cells via the Notch‐1 signaling pathway
APMIS 125(2) (2017)
Jingzhe Yang; Chengli Wang; Zhijie Zhang; Xiaojun Chen; Yusen Jia; Bin Wang; Tao Kong
Functional role and tobacco smoking effects on methylation ofCYP1A1gene in prostate cancer
Oncotarget 7(31) (2016)
Yozo Mitsui; Inik Chang; Taku Kato; Yutaka Hashimoto; Soichiro Yamamura; Shinichiro Fukuhara; Darryn K. Wong; Marisa Shiina; Mitsuho Imai-Sumida; Shahana Majid; Sharanjot Saini; Hiroaki Shiina; Koichi Nakajima; Guoren Deng; Rajvir Dahiya; Yuichiro Tanaka
Endocrine Hypertension and Chronic Kidney Disease
Chronic Kidney Disease and Hypertension (2014)
Christian A. Koch; Christina Pamporaki; Vitaly Kantorovich
Calcitriol in Combination Therapy for Prostate Cancer: Pharmacokinetic and Pharmacodynamic Interactions
Journal of Cancer 7(4) (2016)
Mohamed Ben-Eltriki; Subrata Deb; Emma S. Tomlinson Guns
The UDP-Glycosyltransferase (UGT) Superfamily: New Members, New Functions, and Novel Paradigms
Physiological Reviews 99(2) (2019)
Robyn Meech; Dong Gui Hu; Ross A. McKinnon; Siti Nurul Mubarokah; Alex Z. Haines; Pramod C. Nair; Andrew Rowland; Peter I. Mackenzie
Hormone resistance and neuroendocrine differentiation due to accumulation of genetic lesions during clonal evolution of prostate cancer
Molecular Biology 50(1) (2016)
D. S. Mikhaylenko; G. D. Efremov; A. V. Sivkov; D. V. Zaletaev
The Noninvasive Detection of RARβ2 Promoter Methylation for the Diagnosis of Prostate Cancer
Cell Biochemistry and Biophysics 71(2) (2014)
Tong Zhang; Lei Zhang; Qinggong Yuan; Xiangling Wang; Yi Zhang; Jinhua Wang; Yanping Zhang
Iron Oxide Nanoparticles for Visualization of Prostate Cancer in MRI
Cancers 14(12) (2022)
Avan Kader; Jan O. Kaufmann; Dilyana B. Mangarova; Jana Moeckel; Julia Brangsch; Lisa C. Adams; Jing Zhao; Carolin Reimann; Jessica Saatz; Heike Traub; Rebecca Buchholz; Uwe Karst; Bernd Hamm; Marcus R. Makowski